Investor profile
Schroders Capital has backed 18 European tech companies across 21 funding rounds between 2014 and 2026, joining rounds totalling €2.4B. Most active in Healthtech and Edtech. Data as of 7 Aug 2026.
Also recorded as: Schroders
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| €90M |
| Multiverse | UK | 1 | €80M |
| iOnctura | Switzerland | 1 | €80M |
| Fastned | Netherlands | 1 | €75M |
| Luminance | UK | 1 | €72M |
| tem | UK | 1 | €63M |
| Nutmeg | UK | 2 | €62M |
| haya therapeutics | Switzerland | 1 | €58M |
| Domain Therapeutics | France | 1 | €40M |
| Epsilogen | UK | 1 | €37M |
| Memo Therapeutics | Switzerland | 1 | €26M |
| Araris Biotech | Switzerland | 1 | €24M |
| Be.EV | UK | 1 | €24M |
| Healthy Workers | Netherlands | 1 | €3.6M |
| €132M |
| 2025-05 |
| Artios | Series C | €130M | 2021-07 |
| Artios | Series D+ | €99M | 2025-11 |
| Proeduca | Other | €90M | 2025-07 |
| Multiverse | Other | €80M | 2026-05 |
| iOnctura | Series B | €80M | 2024-06 |
| Fastned | Other | €75M | 2022-10 |
